Jesse Solomon
  1. Partner

Mr. Solomon is a partner in Davis Polk's Litigation Department in Washington DC, practicing in the Antitrust & Competition Group.  Recognized as a prominent antitrust practitioner by Chambers USA and Legal 500 U.S., he also has been named a 2019 D.C. Rising Star by the National Law Journal and nominated by Global Competition Review as 2018’s “Lawyer of the Year (Under 40).”  Mr. Solomon regularly advises clients on the competition law aspects of complex and high-profile mergers, acquisitions, and joint ventures.  In that vein, he frequently develops global strategies for obtaining competition clearance of transactions across international jurisdictions, with particular experience in transactions in the healthcare, pharmaceuticals, chemicals, technology, and consumer products industries.  He routinely represents clients in antitrust investigations of transactions and conduct matters before the Federal Trade Commission and the U.S. Department of Justice.

Mr. Solomon works actively with the LGBTQ+ affinity group at Davis Polk and in 2019 received Davis Polk’s inaugural Inclusive Leadership Award in recognition of his impact on advancing diversity and inclusion efforts at the firm.  

Work Highlights

Selected Antitrust Representations

Healthcare, Pharmaceuticals, and Chemicals
  • Aetna on its $77B sale to CVS Health
  • AstraZeneca on the $119B acquisition proposal by Pfizer
  • Bristol Myers Squibb on its $300M acquisition of IFM
  • CVS Caremark on its $1.25B acquisition of Universal American’s Medicare PDP business
  • Roche on its $4.8B acquisition of Spark Therapeutics
  • Shire on its $62B acquisition by Takeda
  • Smith & Nephew on its:
    • $1.7B acquisition of ArthroCare
    • $350M divestiture of its gynecology business to Medtronic
  • Syngenta on:
    • Its $43B acquisition by ChemChina
    • Its successful defense of a $46.5B takeover proposal by Monsanto
    • Multiple civil class actions in the crop inputs industry
  • Warner Chilcott’s $8.5B acquisition by Actavis
  • Numerous other pharmaceutical and biotech companies in major global transactions
Technology
  • Attunity on its $560M acquisition by Qlik Technologies
  • Blackbaud on its $160M acquisition of MicroEdge
  • Clarivate Analytics on its:
    • $6.8B combination with CPA Global
    • $950M acquisition of Decision Resources Group 
  • Comcast on its:
    • $37.25B joint venture with NBCUniversal
    • Acquisition of Fandango
  • RTL Group in the sale of SpotX to Magnite
  • Special committee of Tribune Publishing on its going-private acquisition by Alden Global Capital
  • Uniti Group on the divestiture purchase of assets sold by CenturyLink in connection with its acquisition of Level 3
  • A major technology company in parallel investigations by the FTC, DOJ and nearly 50 states
Industrial Businesses and Transportation
    • Fibria on its $11B sale to Suzano
    • General Electric on numerous transactions relating to the sale of GE Capital lending units
    • The Greenbrier Companies on its $400M acquisition of American Railcar Industries
    • TRATON (formerly Volkswagen Truck & Bus) on its:
      • $250M joint venture with Navistar
      • $3.7B acquisition of Navistar
Consumer Products
  • ConAgra on the $2.7B sale of its private brands business to TreeHouse Foods
  • Manhattan Beer on its $250M acquisition of Windmill's distribution rights
  • Tyson Foods on its $8.55B acquisition of Hillshire Brands
  • A leading consumer products company in several acquisitions of beverage and nutrition businesses
Financial and Consulting Services
  • BATS Global Markets on its:
    • $3.4B sale to CBOE Global Markets
    • Acquisition of Direct Edge
  • PricewaterhouseCoopers on its sale of its public sector government consulting practice

·      

Recognition

  • Chambers USA – Antitrust: District of Columbia
  • National Law Journal – "D.C. Rising Star," 2019
  • Legal 500 U.S. – Antitrust Merger Control, Next Generation Partner
  • Global Competition Review – "Lawyer of the Year (Under 40)" Nominee, 2018
  • Burton Awards for Legal Achievement – "Distinguished Legal Writing Award," 2013
  • Antitrust Writing Awards – "Best Academic Mergers Article," 2013

Of Note

  • Associate Editor, Antitrust Law Journal
  • Author of articles for a variety of antitrust publications, including Antitrust Magazine, Concurrences, and numerous American Bar Association publications
  • Member, Section of Antitrust Law, American Bar Association

Professional History

  • Partner, 2016-present
  • Associate, 2008-2016
  • Washington DC office, 2010-present
  • Northern California office, 2008-2010

Bar Admissions

  • District of Columbia
  • State of California
  • U.S. Supreme Court
  • U.S. Court of Appeals, D.C. Circuit
  • U.S. District Court, N.D. California
  • U.S. District Court, District of Columbia

Education

  • B.A., English Literature, Emory University, 2001
    • Phi Beta Kappa
    • Robert W. Woodruff Scholar
    • summa cum laude
  • M.A., English Literature, Emory University, 2001
    • summa cum laude
  • J.D., UC Berkeley School of Law, 2008
    • Order of the Coif
    • Senior Notes and Comments Editor, California Law Review

Languages

  • French